Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer

Bewaard in:

Bibliografische gegevens
Gepubliceerd in:	NPJ Breast Cancer vol. 10, no. 1 (2024), p. 26
Hoofdauteur:	Tarantino, Paolo
Andere auteurs:	Leone, Julieta, Vallejo, Carlos T., Freedman, Rachel A., Waks, Adrienne G., Martínez-Sáez, Olga, Garrido-Castro, Ana, Lynce, Filipa, Tayob, Nabihah, Lin, Nancy U., Tolaney, Sara M., Leone, Jose P.
Gepubliceerd in:	Nature Publishing Group
Onderwerpen:	Patients Marital status Histology Population-based studies Medical prognosis Mastectomy Cancer therapies Medical research Oncology Tumors Metropolitan areas Chemotherapy Breast cancer Clinical outcomes
Online toegang:	Citation/Abstract Full Text - PDF
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Omschrijving
Samenvatting:	To evaluate the role of chemotherapy in stage IA triple-negative breast cancer, we conducted a retrospective population-based study including 8601 patients. The use of chemotherapy significantly increased from 2010 to 2019 in patients with T1b and T1c tumors (p = 0.001 and p < 0.001, respectively). Receipt of chemotherapy was associated with improved breast cancer-specific survival (BCSS, adjusted hazard ratio = 0.70; p = 0.006), particularly in patients with T1c tumors (5-year BCSS 94.5% vs. 91.2%).
ISSN:	2374-4677
DOI:	10.1038/s41523-024-00634-6
Bron:	Health & Medical Collection